Vivitrol and the FDA
The problem with corporate medicine

Fixing healthcare with more regulation?


This HND piece is a reaction to an article in The BMJ entitled "Time to stop commercial distortion of healthcare evidence and practice, experts urge." The gist of the story is that we have to figure out a way to temper the influence of evil corporate interests (read Big Pharma) in research results. A related issue is the matter of overdiagnosis and "too much medicine." As the authors put it, evidence needs to be more "trustworthy."

And, of course, since the article was written by academics, the recommendations tend to favor government and the academy having more of a say in these matters. As if neither greed nor bias exists in those worlds.

Besides, very few people would argue that there has been a net improvement in healthcare since the Feds starting controlling it in 1965 with Medicare.

Read the complete article.


Verify your Comment

Previewing your Comment

This is only a preview. Your comment has not yet been posted.

Your comment could not be posted. Error type:
Your comment has been saved. Comments are moderated and will not appear until approved by the author. Post another comment

The letters and numbers you entered did not match the image. Please try again.

As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.

Having trouble reading this image? View an alternate.


Post a comment

Comments are moderated, and will not appear until the author has approved them.

Your Information

(Name is required. Email address will not be displayed with the comment.)